Sort   by:  
 Page size 
UnknownSenolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability.
Not available
S-EPMC10006434 | biostudies-literature
UnknownFisetin is a senotherapeutic that extends health and lifespan.
Not available
S-EPMC6197652 | biostudies-literature
UnknownSenloytics, dasatinib plus quercetin, reduce kidney inflammation, senescent cell abundance, and injury while restoring geroprotective factors in murine diabetic kidney disease.
Not available
S-EPMC12857402 | biostudies-literature
UnknownOrally-active, clinically-translatable senolytics restore α-Klotho in mice and humans.
Not available
S-EPMC9034457 | biostudies-literature
UnknownNew Horizons: Novel Approaches to Enhance Healthspan Through Targeting Cellular Senescence and Related Aging Mechanisms.
Not available
S-EPMC7947756 | biostudies-literature
UnknownSenolytic-Resistant Senescent Cells Have a Distinct SASP Profile and Functional Impact: The Path to Developing Senosensitizers.
Not available
S-EPMC12748526 | biostudies-literature
UnknownReducing Senescent Cell Burden in Aging and Disease.
Not available
S-EPMC7857028 | biostudies-literature
UnknownAged-senescent cells contribute to impaired heart regeneration.
Not available
S-EPMC6516154 | biostudies-literature
UnknownSMAD4 mutations and cross-talk between TGF-β/IFNγ signaling accelerate rates of DNA damage and cellular senescence, resulting in a segmental progeroid syndrome-the Myhre syndrome.
Not available
S-EPMC8190230 | biostudies-literature
UnknownClinicopathological and cellular senescence biomarkers in chronic stalled wounds.
Not available
S-EPMC11323232 | biostudies-literature
Sort   by:  
 Page size